Boundless Bio Assets & Liabilities Overview 1970-1969 | BOLD

Boundless Bio assets & liabilities overview from 1970 to 1969. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
Boundless Bio Annual Assets & Liabilities Overview
(Millions of US $)
Boundless Bio Quarterly Assets & Liabilities Overview
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Boundless Bio Inc. is a clinical stage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers. Boundless Bio Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Neo-Concepts (NCI) $0.022B 0.00
MF (MFI) $0.000B 0.00
Marex Group (MRX) $0.000B 0.00
Loar Holdings (LOAR) $0.000B 0.00
Rubrik (RBRK) $0.000B 0.00
YY (YYGH) $0.000B 0.00